☰

Prof. Dr. Reno Debets (Co-Founder)

by | Jun 14, 2025

Prof. Dr. Reno Debets (Co-Founder) Head of Laboratory of Tumour Immunology, Erasmus MC Prof. Debets, co-founder of Pan Cancer T, and professor in ‘T cell immunity and adoptive therapy of tumours’ has a 20-year track record in adoptive T cell therapy with...

Dr. Michel Briejer

by | Jun 14, 2025

Dr. Michel Briejer Supervisory Director Dr. Michel Briejer is managing partner and joined the venture capital firm Thuja Capital early 2008. He has contributed significantly to building the firm and its successful portfolio of early stage companies in the therapeutics...

Helen Tayton-Martin

by | Jun 14, 2025

Helen Tayton-Martin Supervisory Director Dr. Helen Tayton-Martin has broad pharmaceutical, consulting and biotech company-building experience. She served as Chief Business & Strategy Officer of Adaptimmune plc, a commercial cell therapy developer (NASDAQ: ADAP)...

Dharminder Chahal

by | Jun 14, 2025

Dharminder Chahal Supervisory Director Dharminder Chahal is owner and managing director of Exponential B.V. in which capacity he acts as consultant to Van Herk Investments and companies in the Van Herk Investments portfolio. Furthermore he is CEO and co-founder of...

Prof. Dr. Chris H. Bangma

by | Jun 4, 2025

Prof. Dr. Chris H. Bangma Supervisory Director Prof. Dr. Chris H. Bangma is urologist and Professor of the Department of Urology at Erasmus University Medical Centre in Rotterdam, The Netherlands. Mr. Bangma has extensive experience as a Principle Investigator in...